ArticlePLoS computational biology2025
MVHGCN: Predicting circRNA-disease associations with multi-view heterogeneous graph convolutional neural networks.
Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- CSDPCDA: A miRNA-Mediated Cross-Semantic Regulatory Network Framework for Predicting circRNA-Disease Associations.International journal of molecular sciences · 2026Article
- AGCECDA: attention-guided heterogeneous graph collaborative embedding for circRNA-drug sensitivity association prediction.BMC biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Circular RNA, a class of RNA molecules gaining widespread attentions, has been widely recognized as a potential biomarker for many diseases. In recent years, significant progress has been made in the study of the associations between circRNA and diseases. However, traditional experimental methods are often inefficient and costly, making computational models an effective alternative. Nevertheless, existing computational methods still face challenges such as data sparsity and the difficulty of confirming negative samples, which limits the accuracy of predictions. To address these challenges, a novel computational method, namely MVHGCN, is proposed based on multi-view and graph convolutional networks to predict potential associations between circRNA and diseases. MVHGCN first constructs a heterogeneous graph and generates feature descriptors by integrating multiple databases. Then it extracts different connection views of circRNA and diseases through meta-paths, maximizing the utilization of known association information, and aggregates deep feature information through graph convolutional networks. Finally, a MLP is used to predict the association scores. The experimental results show that MVHGCN significantly outperforms existing methods on benchmark datasets by 5-fold cross-validation. This research provides an effective new approach to studying the associations between circRNAs and diseases, capable of alleviating the problem of data sparsity and accurately identifying potential associations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.